Low Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine

Similar documents
Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives

Jeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers?

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine

Richard Grocott Mason

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

High Sensitivity Troponin Improves Management. But Not Yet

Chest Pain Wave I Webinar. May, 30 th 2017

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Use of Biomarkers for Detection of Acute Myocardial Infarction

CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin

Rapid Disposition of Chest Pain Patients February 2019

Troponin: leaks, bumps and elevations : is it an MI or. question?.

Can point of care cardiac biomarker testing guide cardiac safety during oncology trials?

Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

Reducing the Population Health Burden of Cardiovascular Disease

The use of Cardiac CT and MRI in Clinical Practice

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

Advanced Imaging MRI and CTA

OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

Current and Future Imaging Trends in Risk Stratification for CAD

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Avoiding Pitfalls In PE

My Patient Needs a Stress Test

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Baseline Data Collection Tool

Topic. Updates on Definition of Myocardial Infarction

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

The Emerging Role of Cardiac CT in Cardiovascular Imaging. Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016

63 yo woman with chest pain

Difficult Data Definitions and Scenario s

High-Sensitivity Cardiac Troponin in Suspected ACS

POCUS is the future of the physical exam

FFR-CT Not Ready for Primetime

Acute Coronary Syndrome. Sonny Achtchi, DO

Comments or Questions? me:

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Team members: Felix Krainski, Besiana Liti, William Lane Duvall (ASNC member)

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period

Troponin when is an assay high sensitive?

DISCUSSION QUESTION - 1

Heart Disease in Women: Diagnostic Approaches and Management

Acute Coronary Syndromes: Challenges to Management. Claire Williams November 2017

Setting The setting was secondary care. The economic study was carried out in Hong Kong.

Case Question. Evaluation of Chest pain in the Office and Cardiac Stress Testing

CASES IN ADVANCED IMAGING

Tests I Wish You Had Not Ordered. Scott Girard D.O. FACOI Hospitalist

by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver

Prevention and Treatment of Cardiovascular Disease in :20 Vision in a 20:200 World. Cam Patterson, M.D., M.B.A.

Congreso Nacional del Laboratorio Clínico 2016

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

VanderbiltEM.com ACLS ACEP 2016 Cruising the Literature Cardiology Oxygen Use 10/14/2016. Use 100% O 2 during CPR

Treatment of Acute Coronary Syndromes

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

TOPICS IN EMERGENCY MEDICINE SEMI-FINAL

Chest Pain: To Cath or Not? Part I

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics

Overview. Health and economic burden of coronary artery disease (CAD) Pitfalls in care of patients suspected of having CAD

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

. θωρακικούάλγουςστα εξωτερικά ιατρεία

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC

ROMICAT II - Rule Out Myocardial

Non ST Elevation-ACS. Michael W. Cammarata, MD

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

The San Francisco Syncope Rule to Predict Patients with Serious Outcomes

Agenda. Disclosures. Surgical Mortality: What is High Risk?

TROPONINS HAVE THEY CHANGED YOUR

Update in Perioperative Medicine

Acute Coronary Syndrome

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Data Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR

Disclosure Information

ECG Workshop. Nezar Amir

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose

Clinical Case. Management of ACS Based on ACC/AHA & ESC Guidelines. Clinical Case 4/22/12. UA/NSTEMI: Definition

The Clinical Laboratory Working with Physicians to Improve Patient Care

Welcome! To submit questions during the presentation: or Text:

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

TIA: Updates and Management 2008

By: Diamond Fernandes BSc, ACSM CES, CSCS To learn more about the author, click below

Clinical Controversies in Perioperative Medicine

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

Acute Coronary Syndromes. Erika Newton, MD Emergency Medicine July 2, 2009

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Echocardiographic Evaluation of the Aorta

Transcription:

Disclosure Low Risk Chest Pain No Financial Relationships to Disclose No significant investments or savings Unlimited Expenses Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine Objectives Case 1 Improve speed and accuracy in assessing patients with possible ACS! Avoid pitfalls in the use of cardiac markers to exclude AMI Avoid pitfalls in the use of noninvasive testing to exclude Unstable Angina 54 y.o. M w/ left shoulder ache x 8 hours. Only hx is smoking ¼ ppd Normal exam except marked Left trapezius muscle spasm ECG no ischemia CXR Normal Single 8 hr TnI sent = 0.09 [0.00 0.10 ng/ml] 1

Case 1 Case 1 Was AMI appropriately excluded? 1. Yes 2. No 3. Care is never appropriate at a CME lecture What about Unstable Angina? Other diagnoses? Discharged with Dx of shoulder strain and follow-up by PMD in 1-3 days. Patient is brought back 12 hours later in cardiac arrest A lawsuit is brought and settled out of court Steps in Assessment of ACS 1. Risk Stratify 2. Rule out MI 3. Rule out UA Immediate Delayed How do ACS patients present to our EDs? Gupta, Ann EM 2002-720 cases of AMI CHEST PAIN NO CHEST PAIN (53%) (47%) Shortness of Breath (17%) Cardiac arrest (7%) Dizzy/Weak/Syncope (4%) Abdominal Pain (2%) Other (17%) 2

How do ACS patients present? - Summary - 50% of patients with ACS present like the text books say 50% of patients with ACS present atypically Atypical is TYPICAL AMI : The Cardiac Markers In a patient without ischemia on ECG, it s all about the troponins! AMI exclusion 6 hours after ONSET is accepted although repeating a level 6 hours after ARRIVAL is common AMI exclusion 2-3 hours after ARRIVAL is here (but hasn t reached the guidelines yet) Excluding AMI AMI: ACEP Policy It s about the troponins AMI exclusion is something we can and should do correctly ACEP Clinical Policy Annals EM, Sept 2006 A negative cardiac marker at least 8 hours from symptom onset OR A negative 90 min delta myoglobin + (CKMB or Troponin) OR A negative 2 hr delta CK-MB + Troponin 3

Morrow, Circ, 07 What is a Low Risk Patient? No Ischemia on ECG Initial Cardiac Marker is Negative AMI: Lab Medicine A negative cardiac marker at least 6 hours from symptom onset IF Low Risk A negative cardiac marker at least 12 hours from symptom onset IF Mod-High Risk Case 1 Understanding the Lab 54 y.o. M w/ left shoulder ache x 8 hours. Nl exam and ECG Single 8 hr TnI sent = 0.09 [0.00 0.10 ng/ml] Was AMI appropriately excluded? Assay limit of detection <0.01 99 th percentile = 0.10 10% coefficient of variance (imprecision) = 0.3 4

Understanding the Lab Troponin Leaks <0.01 = Undetectable 0.01 to 0.1 = Detectable (but within normal range ) > 0.1 = Elevated Aviles and Aviles, EM Clinics, 2005 Tachycardia CHF PE Peri/Myocarditis Renal Failure DKA Sepsis Acute Troponin Leaks Chronic Troponin Leaks Morrow, JAMA, 01 Even slight elevations (> 0.1) predict death and adverse events. TnI between 0.1 and 0.4 = 2.5 O.R. for death/mi Han et al, Am J Nephrol, 2009 21 of 107 asymptomatic dialysis pts with mild TnT elevation had 6 fold higher risk of cardiovascular events over 3 years 5

Troponin Leak Pearls Super sensitive assays It s a leak if: 1) They ve had it in the past (more than once) 2) You repeat and it doesn t rise NEJM, Aug 27 2009 Super Sensitive Assays - Summary Ways to miss AMI w/ a negative 6 hr Trop Any detectable level mandates further evaluation - Repeat level and stress testing is safest approach Not in the clinical policies yet, but pretty good evidence that with a sensitive assay, an undetectable level at 0 and 3 hrs excludes AMI As sensitivity increases, we will get an increasing number of false positives Unacceptable Miss the ischemic ECG Troponin not really negative (i.e detectable) Not really 6 hours after onset (stuttering) Acceptable Very tiny percentage of patients still have AMI We didn t miss AMI but unstable angina 6

Unstable Angina: Noninvasive Tests ED Treadmill Understand your non-invasive testing! Outpatient testing Sensitivity Specificity # of Patients Treadmill 68 77 24,074 Nuclear stress 88 77 628 Stress Echo 76 88 1174 Lee NEJM 01 Amsterdam, JACC, 2002 1000 ED pts sent for treadmill w/ a single negative troponin Negative ETT in 64% = 0.2% Event Rate Positive ETT in 13% = 14% Event Rate Nondiagnostic in 23% = 3.6% Event Rate Value of prior stress testing? Lessons from Treadmill testing Nerenberg, AJEM, 07 Compared with no prior testing: A positive prior ETT increases admit rate and rate of adverse events A negative does NOT change admit rate or rate of adverse events A negative exercise treadmill excludes that the current symptoms are due to ACS Confirm that test is diagnostic 85% MPHR (> 6 mets, DP > 22.5 K) Non-diagnostic results need further eval Previous treadmill helpful only if abnormal 7

Outpatient Noninvasive Testing in 72 hours? CT Coronary Angio: The Future? Braunwald, Circ, 02 ACC/AHA Recommends noninvasive testing within 72 hours of ED visit Meyer, Annals EM Showed this was a safe strategy in 1000 low risk Kaiser patients after AMI rule out Radiation Doses Radiation exposure Yearly background = 3 CXR = 0.02 Cardiac cath = 6 Tc-99 Stress Mibi = 8 CTCA: Male = 9 msv (14 if retrospective) CTCA: Female = 12 (21 if retrospective) Smith-Bindman, Arch IM 09 - Actual Doses!!!! CTCA 22 (14-24) msv CT in ACS- My Take Excellent Negative Predictive Value Use only when treadmill unavailable or patient can t exercise Probably best for a moderate risk pt i.e. > 10% ACS risk Identifies other diseases! (Causes other diseases?) 8

How Can We Detect All ACS? How Can We Detect All ACS? The only way to detect all ACS is to test everyone! However, we have seen testing lead to wasted time, money, unnecessary complications and further testing due to non-diagnostic or false positive results DOCUMENT their understanding of the risks of the decision, which are always present DO what you and the patient believe is best Case 1 Implications 54 y.o. M w/ left shoulder ache x 8 hours. Nl exam and ECG Single 8 hr TnI sent = 0.09 [0.00 0.10 ng/ml] Died of Aortic Dissection No CXR was obtained Documentation for chest pain should discuss both doctor s and patient s understanding of risk that is acceptably low but not zero for: Acute MI Unstable Angina Aortic Dissection Pulmonary Embolism 9

Summary Summary The exclusion of AMI and UA are two different processes. After excluding ischemia on ECG: AMI is about the troponins A negative troponin at 6-8 hours after onset Arrival and 3 hours with sensitive markers Beware detectable but non-diagnostic elevations Unstable Angina is about the Non-invasive testing Unstable Angina If using a treadmill, confirm the test is diagnostic 85% MPHR (> 6-10 mets) Non-diagnostic results require further eval It is acceptable to schedule expeditiously as outpatient Beware the previous negative treadmill, especially when symptoms were different 10